{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T17:47:41Z","timestamp":1788716861827,"version":"build-2803163510"},"reference-count":79,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T00:00:00Z","timestamp":1537488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,1]]},"DOI":"10.1093\/qjmed\/hcy215","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T16:37:08Z","timestamp":1537461428000},"page":"171-182","source":"Crossref","is-referenced-by-count":38,"title":["The UK guidelines for management and surveillance of Tuberous Sclerosis Complex"],"prefix":"10.1093","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2688-2529","authenticated-orcid":false,"given":"S","family":"Amin","sequence":"first","affiliation":[{"name":"University Hospitals Bristol, Upper Maudlin Street, Education Centre Level 6, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J C","family":"Kingswood","sequence":"additional","affiliation":[{"name":"Brighton and Sussex University Hospitals, Eastern Rd, Brighton, East Sussex, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P F","family":"Bolton","sequence":"additional","affiliation":[{"name":"King\u2019s College London, Institute of Psychiatry, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Elmslie","sequence":"additional","affiliation":[{"name":"St George\u2019s University Hospitals, Cranmer Terrace, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D P","family":"Gale","sequence":"additional","affiliation":[{"name":"UCL Centre for Nephrology, Royal Free Hospital, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Harland","sequence":"additional","affiliation":[{"name":"Epsom & St Helier Hospital, Wrythe Lane, Carshalton, Surrey, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S R","family":"Johnson","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Faculty of Medicine & Health Sciences, Nottingham University, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Parker","sequence":"additional","affiliation":[{"name":"Addenbrooke's Hospital, Hills Road, Cambridge, Cambridgeshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J R","family":"Sampson","sequence":"additional","affiliation":[{"name":"Division of Cancer and Genetics, University of Cardiff, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Smeaton","sequence":"additional","affiliation":[{"name":"Tuberous Sclerosis Association, CAN Mezzanine, 32-36 Loman Street, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Wright","sequence":"additional","affiliation":[{"name":"University of Bristol, The Priory Road Complex, Priory Road, Bristol, Clifton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F J","family":"O\u2019Callaghan","sequence":"additional","affiliation":[{"name":"UCL GOS Institute of Child Health, 41 Clinical Neurosciences Section, 4th Floor Philip Ullman Wing South, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,9,21]]},"reference":[{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"van Slegtenhorst","year":"1997","journal-title":"Science"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B2","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","year":"1993","journal-title":"Cell"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","article-title":"Epidemiology of tuberous sclerosis","volume":"615","author":"Osborne","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B4","doi-asserted-by":"crossref","first-page":"13571","DOI":"10.1073\/pnas.202476899","article-title":"Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling","volume":"99","author":"Tee","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1469-1809.2003.00012.x","article-title":"Tuberous sclerosis: from tubers to mTOR","volume":"67","author":"Kwiatkowski","year":"2003","journal-title":"Ann Hum Genet"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B6","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1287\/mnsc.9.3.458","article-title":"An experimental application of the Delphi method to the use of experts","volume":"9","author":"Dalkey","year":"1963","journal-title":"Manag Sci"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1108\/14777260310469319","article-title":"Delphi: myths and reality","volume":"17","author":"Mullen","year":"2003","journal-title":"J Health Organ Manag"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(87)90416-8","article-title":"Evidence that the gene for tuberous sclerosis is on chromosome 9","volume":"329","author":"Fryer","year":"1987","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/ng0992-37","article-title":"Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease","volume":"2","author":"Kandt","year":"1992","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/316951","article-title":"Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs","volume":"68","author":"Dabora","year":"2001","journal-title":"Am J Hum Genet"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1086\/514888","article-title":"Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene","volume":"61","author":"Sampson","year":"1997","journal-title":"Am J Hum Genet"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B13"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1177\/08830738040190091101","article-title":"Molecular genetic basis of tuberous sclerosis complex: from bench to bedside","volume":"19","author":"Au","year":"2004","journal-title":"J Child Neurol"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B15","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1346-8138.1992.tb03805.x","article-title":"Tuberous sclerosis complex: genetic aspects","volume":"19","author":"Northrup","year":"1992","journal-title":"J Dermatol"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B16","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0140-6736(75)90343-8","article-title":"Infantile spasms and subsequent appearance of tuberous sclerosis syndrome","volume":"306","author":"Pampiglione","year":"1975","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B17","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/adc.2003.026815","article-title":"The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex","volume":"89","author":"O'Callaghan","year":"2004","journal-title":"Arch Dis Child"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/088307380401900601","article-title":"Infantile spasms: therapy and outcome","volume":"19","author":"Riikonen","year":"2004","journal-title":"J Child Neurol"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1469-8749.1987.tb02135.x","article-title":"Psychiatric disorder among children with tuberous sclerosis","volume":"29","author":"Hunt","year":"2008","journal-title":"Dev Med Child Neurol"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B20","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1212\/WNL.43.11.2322","article-title":"Infantile spasms: outcome and prognostic factors of cryptogenic and symptomatic groups","volume":"43","author":"Koo","year":"1993","journal-title":"Neurology"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1528-1167.2009.02341.x","article-title":"Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies","volume":"51","author":"Wong","year":"2010","journal-title":"Epilepsia"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B22","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B23","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jpeds.2013.12.053","article-title":"Mammalian target of rapamycin inhibitors for intractable epilepsy and subependymal giant cell astrocytomas in tuberous sclerosis complex","volume":"164","author":"Cardamone","year":"2014","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00381-013-2185-6","article-title":"Rapamycin has a beneficial effect on controlling epilepsy in children with tuberous sclerosis complex: results of 7 children from a cohort of 86","volume":"30","author":"Canpolat","year":"2014","journal-title":"Childs Nerv Syst"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B25","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"French","year":"2016","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejpn.2011.03.010","article-title":"Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex","volume":"15","author":"J\u00f3\u017awiak","year":"2011","journal-title":"Eur J Paediatr Neurol"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B27","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/dmcn.13352","article-title":"Causes of mortality in individuals with tuberous sclerosis complex","volume":"59","author":"Amin","year":"2017","journal-title":"Dev Med Child Neurol"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B28","year":"2012"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejpn.2012.10.005","article-title":"The outcome of surgical management of subependymal giant cell astrocytoma in tuberous sclerosis complex","volume":"17","author":"Amin","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B30","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1212\/01.WNL.0000142039.14522.1A","article-title":"Subependymal giant cell tumors in tuberous sclerosis complex","volume":"63","author":"Goh","year":"2004","journal-title":"Neurology"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/088307389801300405","article-title":"Early diagnosis of subependymal giant cell astrocytoma in patients with tuberous sclerosis","volume":"13","author":"Torres","year":"1998","journal-title":"J Child Neurol"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B33","doi-asserted-by":"crossref","first-page":"e0158476.","DOI":"10.1371\/journal.pone.0158476","article-title":"Long-term use of everolimus in patients with tuberous sclerosis complex: final results from the EXIST-1 study","volume":"11","author":"Franz","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B34","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF01048239","article-title":"Autism and tuberous sclerosis","volume":"22","author":"Smalley","year":"1992","journal-title":"J Autism Dev Disord"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B35","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1017\/S0012162206001277","article-title":"Autistic regression associated with seizure onset in an infant with tuberous sclerosis","volume":"48","author":"Humphrey","year":"2006","journal-title":"Dev Med Child Neurol"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B36","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/brain\/awf124","article-title":"Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex","volume":"125","author":"Bolton","year":"2002","journal-title":"Brain"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B37","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jfma.2014.02.008","article-title":"The relationship of neuroimaging findings and neuropsychiatric comorbidities in children with tuberous sclerosis complex","volume":"114","author":"Huang","year":"2015","journal-title":"J Formos Med Assoc"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B38","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.yebeh.2007.07.010","article-title":"Psychiatric comorbid conditions in a clinic population of 241 patients with tuberous sclerosis complex","volume":"11","author":"Muzykewicz","year":"2007","journal-title":"Epilepsy Behav"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B39","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1177\/08830738040190090601","article-title":"Behavioral and cognitive aspects of tuberous sclerosis complex","volume":"19","author":"Prather","year":"2004","journal-title":"J Child Neurol"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B40","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1464-410X.2004.05046.x","article-title":"An epidemiological study of renal pathology in tuberous sclerosis complex","volume":"94","author":"O'Callaghan","year":"2004","journal-title":"BJU Int"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B41","year":"1900"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-5347(01)63072-6","article-title":"Renal lesion growth in children with tuberous sclerosis complex","volume":"160","author":"Ewalt","year":"1998","journal-title":"J Urol"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B43","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0025-6196(12)61196-3","article-title":"Causes of death in patients with tuberous sclerosis","volume":"66","author":"Shepherd","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B44","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/jmg.33.6.480","article-title":"A cross sectional study of renal involvement in tuberous sclerosis","volume":"33","author":"Cook","year":"1996","journal-title":"J Med Genet"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B45","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B46","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1056\/NEJMc072500","article-title":"Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis","volume":"358","author":"Davies","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B47","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1158\/1078-0432.CCR-11-0445","article-title":"Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial","volume":"17","author":"Davies","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B48","doi-asserted-by":"crossref","first-page":"e23379.","DOI":"10.1371\/journal.pone.0023379","article-title":"Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease","volume":"6","author":"Dabora","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B49","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B50","doi-asserted-by":"crossref","first-page":"e0180939.","DOI":"10.1371\/journal.pone.0180939","article-title":"Everolimus long-term use in patients with tuberous sclerosis complex: four-year update of the EXIST-2 study","volume":"12","author":"Bissler","year":"2017","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B51","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B52","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B53","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00467-017-3806-1","article-title":"The effect of everolimus on renal angiomyolipoma in pediatric patients with tuberous sclerosis being treated for subependymal giant cell astrocytoma","volume":"33","author":"Bissler","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B54","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/ndt\/gfu013","article-title":"The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1","volume":"29","author":"Kingswood","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1053\/rmed.2001.1206","article-title":"Lymphangioleiomyomatosis and tuberous sclerosis","volume":"96","author":"Hancock","year":"2002","journal-title":"Respir Med"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B56","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2559.1993.tb00158.x","article-title":"Lymphangiomyomatosis and angiomyolipoma: closely related entities characterized by hamartomatous proliferation of HMB-45-positive smooth muscle","volume":"22","author":"Chan","year":"1993","journal-title":"Histopathology"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B57","doi-asserted-by":"crossref","first-page":"687.","DOI":"10.7326\/0003-4819-146-9-200705010-00022","article-title":"Sirolimus treatment for pulmonary lymphangioleiomyomatosis","volume":"146","author":"Taill\u00e9","year":"2007","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B58","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/ajcp\/93.5.609","article-title":"Pulmonary lymphangioleiomyomatosis and steroid receptors. An immunocytochemical study","volume":"93","author":"Berger","year":"1990","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B59","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/CLEP.S50780","article-title":"Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis","volume":"7","author":"Taveira-DaSilva","year":"2015","journal-title":"Clin Epidemiol"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B60","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B61","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2165\/11634580-000000000-00000","article-title":"Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex: a double-blind, randomized, controlled trial to evaluate the safety and efficacy of topically applied rapamycin","volume":"12","author":"Koenig","year":"2012","journal-title":"Drugs R D"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/8404378","article-title":"Sirolimus ointment for facial angiofibromas in individuals with tuberous sclerosis complex","volume":"2017","author":"Amin","year":"2017","journal-title":"Int Sch Res Notices."},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B63","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jamadermatol.2018.1408","article-title":"Sirolimus gel treatment vs. placebo for facial angiofibromas in patients with tuberous sclerosis complex: a randomized clinical trial","volume":"154","author":"Wataya-Kaneda","year":"2018","journal-title":"JAMA Dermatol"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B64","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jamadermatol.2018.0464","article-title":"Efficacy and safety of topical rapamycin in patients with facial angiofibromas secondary to tuberous sclerosis complex: the TREATMENT randomized clinical trial","volume":"154","author":"Koenig","year":"2018","journal-title":"JAMA Dermatol"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B65","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00106-007-1618-5","article-title":"Laser skin resurfacing and fibrin sealing as successful treatment for facial angiofibromas in tuberous sclerosis","volume":"55","author":"Pantelis","year":"2007","journal-title":"HNO"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B66","doi-asserted-by":"crossref","first-page":"161.","DOI":"10.1136\/archdischild-2012-303036","article-title":"Glossal hamartoma in tuberous sclerosis","volume":"98","author":"Amin","year":"2013","journal-title":"Arch Dis Child"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B67","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0030-4220(91)90523-F","article-title":"Enamel pitting: a common symptom of tuberous sclerosis","volume":"71","author":"Mlynarczyk","year":"1991","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B68","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jaad.2006.11.019","article-title":"Oral findings in 58 adults with tuberous sclerosis complex","volume":"56","author":"Sparling","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B69","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0002-9149(03)00677-5","article-title":"Association between cardiac tumors and tuberous sclerosis in the fetus and neonate","volume":"92","author":"Tworetzky","year":"2003","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B70","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00383-007-1875-0","article-title":"Cardiac rhabdomyoma as an unusual mediastinal mass in a newborn","volume":"23","author":"Karnak","year":"2007","journal-title":"Pediatr Surg Int"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B71","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1067\/S0022-3476(03)00250-6","article-title":"Left ventricular outflow obstruction in rhabdomyoma of infancy: meta-analysis of the literature","volume":"143","author":"Verhaaren","year":"2003","journal-title":"J Pediatr"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B72","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2165\/00148581-200810050-00004","article-title":"Current management of tuberous sclerosis complex","volume":"10","author":"Krueger","year":"2008","journal-title":"Paediatr Drugs"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B73","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1542\/peds.2011-3476","article-title":"Everolimus: a challenging drug in the treatment of multifocal inoperable cardiac rhabdomyoma","volume":"130","author":"Demir","year":"2012","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B74","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1749-6632.1991.tb37744.x","article-title":"Ophthalmic manifestations of tuberous sclerosis","volume":"615","author":"Robertson","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B75","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1001\/archopht.1976.03910040149003","article-title":"Retinal lesions in tuberous sclerosis","volume":"94","author":"Nyboer","year":"1976","journal-title":"Arch Ophthalmol"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B76","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/bjo.85.4.420","article-title":"Ophthalmic manifestations of tuberous sclerosis: a population based study","volume":"85","author":"Rowley","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B77","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3928\/0191-3913-19811101-12","article-title":"Iris and fundus pigmentary changes in tuberous sclerosis","volume":"18","author":"Lucchese","year":"1981","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B78","first-page":"771","article-title":"The incidence of ocular lesions in tuberous sclerosis","volume":"7","author":"Shelton","year":"1975","journal-title":"Ann Ophthalmol"},{"key":"key\n\t\t\t\t2019022708503869000_hcy215-B79","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0420.2006.00781.x","article-title":"Current treatment modalities for exudative retinal hamartomas secondary to tuberous sclerosis: review of the literature","volume":"85","author":"Mennel","year":"2006","journal-title":"Acta Ophthalmol Scand"}],"container-title":["QJM: An International Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/qjmed\/article-pdf\/112\/3\/171\/27988713\/hcy215.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T04:43:31Z","timestamp":1662093811000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/article\/112\/3\/171\/5104881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,21]]},"references-count":79,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,9,21]]},"published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hcy215","relation":{},"ISSN":["1460-2725","1460-2393"],"issn-type":[{"value":"1460-2725","type":"print"},{"value":"1460-2393","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,3]]},"published":{"date-parts":[[2018,9,21]]}}}